Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?
Cavalcanti Neto MP, Aquino JS, Romão da Silva LF, de Oliveira Silva R, Guimarães KSL, de Oliveira Y, de Souza EL, Magnani M, Vidal H, de Brito Alves JL.
Cavalcanti Neto MP, et al. Among authors: de souza el, de oliveira y, de oliveira silva r, de brito alves jl.
Pharmacol Res. 2018 Apr;130:152-163. doi: 10.1016/j.phrs.2018.01.020. Epub 2018 Feb 14.
Pharmacol Res. 2018.
PMID: 29410236
Review.